Anteo Diagnostics

    Author //

      No items found.

    As published in CK Momentum Issue 9 (Click here to download)

    John Toigo and Kate Gardner in our Corporate Team, recently acted as the Australian lawyers for Anteo Diagnostics Limited (ASX:ADO), an Australian listed biotech company, in its acquisition of 100% of DIAsource ImmunoAssays S.A., a Belgium based diagnostics company, which operates in 75 countries.

    This is a transformational acquisition for Anteo, providing it with an established global distribution platform, manufacturing capabilities and a significantly broadened product range. As part of this transaction John and Kate also advised Anteo on its capital raising activities (including a rights issue) to fund the acquisition.


    This bulletin is produced as general information in summary for clients and subscribers and should not be relied upon as a substitute for detailed legal advice or as a basis for formulating business or other decisions. ClarkeKann asserts copyright over the contents of this document. This bulletin is produced by ClarkeKann. It is intended to provide general information in summary form on legal topics, current at the time of publication. The contents do not constitute legal advice and should not be relied upon as such. Formal legal advice should be sought in particular matters. Liability limited by a scheme approved under professional standards legislation. Privacy Policy
    < Back to Articles


Our greatest asset is our talented and committed people – they enjoy what they do and value the opportunity to work together and with our clients. Our people are from diverse backgrounds and approach their work with intellectual rigour and enthusiasm.



ClarkeKann has received the Australia-Taiwan Business Excellence Award for our efforts promoting and advising on most of the major investments from Taiwan into Australia over the last 20 years. Click below for more details about Foreign Investment. VIEW MORE


Click below to subscribe to our publications and to receive the latest newsVIEW MORE